|
Pavlova M.G.
Vildagliptin – 15 years in active service with diabetologists
|
№2 / 2024
|
|
M.G. Pavlova
Vildagliptin - new opportunities in the treatment of type 2 diabetes mellitus
|
№11-12 / 2022
|
|
V.I.Simanenkov, S.V. Tikhonov
GASTROENTEROLOGICAL ASPECTS OF BARIATRIC SURGERY
|
№s5-16 / 2016
|
|
D.V. Kurkin, E.V. Volotova, D.A. Bakulin, E.M. Lomkina, I.N. Tyurenkov
INCRETIN SYSTEM AS PROMISING PHARMACOLOGICAL TARGET FOR HYPOGLYCEMIC THERAPY
|
№5 / 2016
|
|
A.M. Mkrtumyan
ALOGLIPTIN – EFFECTIVE AND SAFE DIPEPTIDYL PEPTIDASE-4 INHIBITOR IN THE THERAPY OF TYPE 2 DIABETES MELLITUS
|
№5 / 2015
|
|
I.Yu.Demidova
The Clinical Advantages Of The First Human Glp-1 Analogue Liraglutide In The Treatment Of Patients With Type 2 Diabetes Mellitus
|
№5 / 2013
|
|
M. B. Antsiferov, G. Schernthaner, A.S.Ametov
Innovative Hypoglycemic Therapy: A New Strategy For An Old Problem
|
№5 / 2013
|
|
L.A.Ruyatkina 1, M.Yu.Sorokin 2
Choice Of Gliptins In Different Clinical Situations – Comments To Patient Portraitscentral Tibetian Medical Paintings.
|
№20 / 2012
|
|
G.R. Galstyan
Multivariable Management Of Type 2 Diabetes Mellitus: What Are Our Current Potentials
|
№16 / 2012
|
|
A.M. Shilov, A.G. Abdullayeva
Features Of Treatment Of Glucose Intolerance In Patients With Abdominal-visceral Obesity At Early Stages Of Its Development
|
№11 / 2012
|
|
M.B. Antsiferov
Application Of Vildagliptin In Combination With Insulin In Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antciferov
Galvus And Galvus Met In Treatment Of Elderly Patients With Type 2 Diabetes Mellitu
|
№16 / 2011
|
Русский
